123 related articles for article (PubMed ID: 21606082)
1. Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis.
Giannarelli C; Cimmino G; Connolly TM; Ibanez B; Ruiz JM; Alique M; Zafar MU; Fuster V; Feuerstein G; Badimon JJ
Eur Heart J; 2012 Jan; 33(2):264-73. PubMed ID: 21606082
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E1 dose-dependently promotes stability of atherosclerotic plaque in a rabbit model.
Bai W; Zheng X; Zhou L; Li H
Can J Physiol Pharmacol; 2012 Feb; 90(2):131-9. PubMed ID: 22309388
[TBL] [Abstract][Full Text] [Related]
3. Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis.
Ibanez B; Vilahur G; Cimmino G; Speidl WS; Pinero A; Choi BG; Zafar MU; Santos-Gallego CG; Krause B; Badimon L; Fuster V; Badimon JJ
J Am Coll Cardiol; 2008 Mar; 51(11):1104-9. PubMed ID: 18342230
[TBL] [Abstract][Full Text] [Related]
4. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
[TBL] [Abstract][Full Text] [Related]
5. The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging.
Corti R; Osende JI; Fallon JT; Fuster V; Mizsei G; Jneid H; Wright SD; Chaplin WF; Badimon JJ
J Am Coll Cardiol; 2004 Feb; 43(3):464-73. PubMed ID: 15013132
[TBL] [Abstract][Full Text] [Related]
6. Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type).
Ibanez B; Giannarelli C; Cimmino G; Santos-Gallego CG; Alique M; Pinero A; Vilahur G; Fuster V; Badimon L; Badimon JJ
Atherosclerosis; 2012 Jan; 220(1):72-7. PubMed ID: 22030095
[TBL] [Abstract][Full Text] [Related]
7. Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect.
Gómez-Garre D; Muñoz-Pacheco P; González-Rubio ML; Aragoncillo P; Granados R; Fernández-Cruz A
Br J Pharmacol; 2009 Apr; 156(8):1218-27. PubMed ID: 19222481
[TBL] [Abstract][Full Text] [Related]
8. Antihypercholesterolemic and antioxidant efficacies of zerumbone on the formation, development, and establishment of atherosclerosis in cholesterol-fed rabbits.
Hemn HO; Noordin MM; Rahman HS; Hazilawati H; Zuki A; Chartrand MS
Drug Des Devel Ther; 2015; 9():4173-208. PubMed ID: 26347047
[TBL] [Abstract][Full Text] [Related]
9. Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin.
Kanshana JS; Khanna V; Singh V; Jain M; Misra A; Kumar S; Farooqui M; Barthwal MK; Dikshit M
J Cardiovasc Pharmacol; 2017 May; 69(5):314-325. PubMed ID: 28207427
[TBL] [Abstract][Full Text] [Related]
10. LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse.
Quinet EM; Basso MD; Halpern AR; Yates DW; Steffan RJ; Clerin V; Resmini C; Keith JC; Berrodin TJ; Feingold I; Zhong W; Hartman HB; Evans MJ; Gardell SJ; DiBlasio-Smith E; Mounts WM; LaVallie ER; Wrobel J; Nambi P; Vlasuk GP
J Lipid Res; 2009 Dec; 50(12):2358-70. PubMed ID: 19318684
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin reduces expression and activity of lipoprotein-associated phospholipase A(2) in the aorta of hypercholesterolaemic atherosclerotic rabbits.
Qiao Z; Ren J; Chen H
J Int Med Res; 2009; 37(4):1029-37. PubMed ID: 19761685
[TBL] [Abstract][Full Text] [Related]
12. Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin.
Vucic E; Calcagno C; Dickson SD; Rudd JH; Hayashi K; Bucerius J; Moshier E; Mounessa JS; Roytman M; Moon MJ; Lin J; Ramachandran S; Tanimoto T; Brown K; Kotsuma M; Tsimikas S; Fisher EA; Nicolay K; Fuster V; Fayad ZA
JACC Cardiovasc Imaging; 2012 Aug; 5(8):819-28. PubMed ID: 22897996
[TBL] [Abstract][Full Text] [Related]
13. Effect of Si-Miao-Yong-An on the stability of atherosclerotic plaque in a diet-induced rabbit model.
Peng L; Li M; Xu YZ; Zhang GY; Yang C; Zhou YN; Li LJ; Zhang JP
J Ethnopharmacol; 2012 Aug; 143(1):241-8. PubMed ID: 22750436
[TBL] [Abstract][Full Text] [Related]
14. HDL (High-Density Lipoprotein) Remodeling and Magnetic Resonance Imaging-Assessed Atherosclerotic Plaque Burden: Study in a Preclinical Experimental Model.
Ben-Aicha S; Casaní L; Muñoz-García N; Joan-Babot O; Peña E; Aržanauskaitė M; Gutierrez M; Mendieta G; Padró T; Badimon L; Vilahur G
Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2481-2493. PubMed ID: 32847390
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Atherosclerosis Progression, Intimal Hyperplasia, and Oxidative Stress by Simvastatin and Ivabradine May Reduce Thoracic Aorta's Stiffness in Hypercholesterolemic Rabbits.
Koniari I; Mavrilas D; Apostolakis E; Papadimitriou E; Papadaki H; Papalois A; Poimenidi E; Xanthopoulou I; Hahalis G; Alexopoulos D
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):412-22. PubMed ID: 26612090
[TBL] [Abstract][Full Text] [Related]
16. Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy.
Zhang L; Liu Y; Lu XT; Wu YL; Zhang C; Ji XP; Wang R; Liu CX; Feng JB; Jiang H; Xu XS; Zhao YX; Zhang Y
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2004-14. PubMed ID: 19801495
[TBL] [Abstract][Full Text] [Related]
17. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ
Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609
[TBL] [Abstract][Full Text] [Related]
18. Liver X receptors as potential therapeutic targets in atherosclerosis.
Zhu Y; Li Y
Clin Invest Med; 2009 Oct; 32(5):E383-94. PubMed ID: 19796580
[TBL] [Abstract][Full Text] [Related]
19. Effects of simvastatin on NF-kappaB-DNA binding activity and monocyte chemoattractant protein-1 expression in a rabbit model of atherosclerosis.
Yang X; Wang L; Zeng H; Dubey L; Zhou N; Pu J
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(2):194-8. PubMed ID: 16850745
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin suppresses apoptosis in vulnerable atherosclerotic plaques through regulating the expression of p(53), Bcl-2 and Bcl-xL.
Qin W; Lu Y; Zhan C; Shen T; Dou L; Man Y; Wang S; Xiao C; Bian Y; Li J
Cardiovasc Drugs Ther; 2012 Feb; 26(1):23-30. PubMed ID: 22038096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
